Cargando…

SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells

In several carcinomas, the SET Domain Containing 3, Actin Histidine Methyltransferase (SETD3) is associated with oncogenesis. However, there is little knowledge about the role of SETD3 in the progression and prognosis of breast cancer. In this study, we first analyzed the prognostic value of SETD3 i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Nourhan, Rutsch, Niklas, Győrffy, Balázs, Espinoza-Sánchez, Nancy Adriana, Götte, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010743/ https://www.ncbi.nlm.nih.gov/pubmed/32042016 http://dx.doi.org/10.1038/s41598-020-59057-5

Ejemplares similares

Differential impact of classical and non-canonical NF-κB pathway-related gene expression on the survival of breast cancer patients
por: Espinoza-Sánchez, Nancy Adriana, et al.
Publicado: (2019)

Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients
por: Grillo, Paulina Karin, et al.
Publicado: (2021)

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
por: Győrffy, Balázs
Publicado: (2021)

The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis
por: Hillemeyer, Lara, et al.
Publicado: (2022)

Multigene prognostic tests in breast cancer: past, present, future
por: Győrffy, Balázs, et al.
Publicado: (2015)

The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy
por: Zhu, Chenjing, et al.
Publicado: (2019)

The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
por: Riecks, Jette, et al.
Publicado: (2022)

Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells
por: Valla, Sofía, et al.
Publicado: (2021)

QPRT Acts as an Independent Prognostic Factor in Invasive Breast Cancer
por: Zhou, Lili, et al.
Publicado: (2022)

Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
por: Hilgers, Katharina, et al.
Publicado: (2022)

Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes
por: Nassar, Eyyad, et al.
Publicado: (2021)

SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis
por: Huang, Run, et al.
Publicado: (2017)

Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis
por: Mihály, Zsuzsanna, et al.
Publicado: (2013)

USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer
por: Rossi, Fabiana Alejandra, et al.
Publicado: (2021)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters
por: Al Sarakbi, W, et al.
Publicado: (2009)

The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor
por: Hassan, Nourhan, et al.
Publicado: (2023)

Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer
por: Győrffy, Balázs
Publicado: (2023)

Survival analysis in breast cancer using proteomic data from four independent datasets
por: Ősz, Ágnes, et al.
Publicado: (2021)

CircSETD2 inhibits YAP1 by interaction with HuR during breast cancer progression
por: Jing, Lan, et al.
Publicado: (2023)

Prognostic molecular markers in early breast cancer
por: Esteva, Francisco J, et al.
Publicado: (2004)

RECK is not an independent prognostic marker for breast cancer
por: Gomes, Luciana R., et al.
Publicado: (2015)

An assessment of prognostic immunity markers in breast cancer
por: Yang, Benlong, et al.
Publicado: (2018)

Number of apoptotic cells as a prognostic marker in invasive breast cancer
por: Jong, J S de, et al.
Publicado: (2000)

Gene Expression Profiling in Early Breast Cancer—Patient Stratification Based on Molecular and Tumor Microenvironment Features
por: Munkácsy, Gyöngyi, et al.
Publicado: (2022)

New network topology approaches reveal differential correlation patterns in breast cancer
por: Bockmayr, Michael, et al.
Publicado: (2013)

CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer
por: Zhang, Lianmei, et al.
Publicado: (2023)

HS2ST1‐dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior
por: Vijaya Kumar, Archana, et al.
Publicado: (2020)

The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans
por: Hassan, Nourhan, et al.
Publicado: (2023)

SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer
por: Bao, Jisheng, et al.
Publicado: (2016)

TIGIT as a Novel Prognostic Marker for Immune Infiltration in Invasive Breast Cancer
por: Guo, Chenming, et al.
Publicado: (2023)

Survivin expression as a prognostic marker for breast cancer
por: Quidute, Patricia, et al.
Publicado: (2023)

Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors
por: Posta, Máté, et al.
Publicado: (2023)

Potential options for managing LOX+ ER− breast cancer patients
por: Han, Yong, et al.
Publicado: (2016)

MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
por: Skucha, Anna, et al.
Publicado: (2018)

ZKSCAN5 Activates VEGFC Expression by Recruiting SETD7 to Promote the Lymphangiogenesis, Tumour Growth, and Metastasis of Breast Cancer
por: Li, Jingtong, et al.
Publicado: (2022)

Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer
por: Schölch, Sebastian, et al.
Publicado: (2019)

SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells
por: O'Neill, Daniel J, et al.
Publicado: (2014)

The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin
por: Driskell, Iwona, et al.
Publicado: (2012)

PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer
por: Munkácsy, G, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nbohd1ghv14df50sbumneb0i1v